Osteoarthritis: Osteoporotic OA: a reasonable target for bone-acting agents.
Nat Rev Rheumatol
; 9(8): 448-50, 2013 Aug.
Article
em En
| MEDLINE
| ID: mdl-23857129
ABSTRACT
Beneficial effects of bone-acting drugs in osteoarthritis (OA) are increasingly reported, but reliable conclusions regarding their efficacy are hindered by methodological drawbacks in study design. Identifying patients with osteoporotic OA, a phenotype defined by decreased density associated with high remodelling in subchondral bone, might improve the success of bone-directed agents.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Osteoporose
/
Osteoartrite do Joelho
/
Difosfonatos
/
Conservadores da Densidade Óssea
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article